Filtered By:
Drug: Xolair
Management: Medicaid
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3 results found since Jan 2013.
What to Know About the Latest Advances in Managing Severe Asthma
Graphs and charts don’t always tell the whole story. Numbers can be deceiving. But anyone who looks at U.S. trends in asthma mortality can see, without squinting, that things are moving in the right direction.
A 2019 analysis in the American Journal of Respiratory and Critical Care Medicine found that from 1999 to 2015, asthma mortality fell by 43%. “The decrease in asthma-related mortality was consistent in both sexes and in all race groups, with the largest decrease in patients older than 65 years,” the authors concluded. Figures from the U.S. Centers for Disease Control and Prevention indicate that the...
Source: TIME: Health - June 23, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Real-world effectiveness of benralizumab: results from the ZEPHYR 1 Study
CONCLUSION: Patients with severe asthma treated with benralizumab experienced significant clinical and economic benefits in the real world, as demonstrated by the reduction in exacerbations and HCRU.PMID:35247595 | DOI:10.1016/j.anai.2022.02.017
Source: Annals of Allergy, Asthma and Immunology - March 5, 2022 Category: Allergy & Immunology Authors: Yen Chung Rohit Katial Fan Mu Erin E Cook Joshua Young Danni Yang Keith A Betts Donna D Carstens Source Type: research
